Marie‐Noëlle Bizot

Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren

Sujata Vaidyanathan, Gian Camenisch, Helmut Schuetz et al. · The Journal of Clinical Pharmacology · 2008 · 103 citations

Medicine, Pharmacokinetics, Pharmacology +13

Everolimus Therapeutic Concentration Range Defined from a Prospective Trial with Reduced-Exposure Cyclosporine in De Novo Kidney Transplantation

John M. Kovarik, Hélio Tedesco‐Silva, Julio Pascual et al. · Therapeutic Drug Monitoring · 2004 · 99 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetics of the Oral Direct??Renin Inhibitor Aliskiren Alone and??in Combination with Irbesartan in??Renal Impairment

Sujata Vaidyanathan, Hilde Bigler, C M Yeh et al. · Clinical Pharmacokinetics · 2007 · 67 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects

Sujata Vaidyanathan, Joanne Jermany, Ching‐Ming Yeh et al. · British Journal of Clinical Pharmacology · 2006 · 66 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacokinetics, Safety, and Tolerability of the Oral Renin Inhibitor Aliskiren in Patients With Hepatic Impairment

Sujata Vaidyanathan, Vance Warren, Ching‐Ming Yeh et al. · The Journal of Clinical Pharmacology · 2007 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +16